Literature DB >> 19223429

Infrequently performed studies in nuclear medicine: part 2.

Anita MacDonald1, Steven Burrell.   

Abstract

Nuclear medicine is a diverse medical field, encompassing a wide range of studies. Many studies are performed on a daily basis, whereas some nuclear medicine studies are performed on a more infrequent basis. The following article is the second article in a 2-part series on infrequently performed studies in nuclear medicine. The procedures reviewed include CSF shunt imaging, brain death scintigraphy, testicular scanning, quantitative lung perfusion studies, lymphoscintigraphy, and salivary gland scintigraphy. This article may be of use to technologists faced with the task of performing one of these uncommon studies. After reviewing the article, the reader should be able to list the indications for each study, list the recommended doses, describe the proper method of dose administration for each study, discuss patient preparation for each procedure, and describe issues that may arise when performing these studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223429     DOI: 10.2967/jnmt.108.057851

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  6 in total

1.  Two signs indicative of successful access in nuclear medicine cerebrospinal fluid diversionary shunt studies.

Authors:  Mohammed S Bermo; Hedieh Khalatbari; Marguerite T Parisi
Journal:  Pediatr Radiol       Date:  2018-05-08

Review 2.  Nuclear medicine and the emergency department patient: an illustrative case-based approach.

Authors:  Fatemeh Behnia; Joel A Gross; Monica Ragucci; Serena Monti; Marcello Mancini; Shana Elman; Hubert Vesselle; Lorenzo Mannelli
Journal:  Radiol Med       Date:  2014-08-13       Impact factor: 3.469

3.  Sicca complex among Egyptian patients with chronic hepatitis C virus infection.

Authors:  Zeinab Nawito; Amr Amin; Sohier Abu El-Fadl; Khaled Abu El Einen
Journal:  Clin Rheumatol       Date:  2011-04-13       Impact factor: 2.980

4.  Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study.

Authors:  Hojjat Ahmadzadehfar; Kambiz Rahbar; Stefan Kürpig; Martin Bögemann; Michael Claesener; Elisabeth Eppard; Florian Gärtner; Sebastian Rogenhofer; Michael Schäfers; Markus Essler
Journal:  EJNMMI Res       Date:  2015-06-20       Impact factor: 3.138

5.  Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management.

Authors:  Sonia Mahajan; Ravinder K Grewal; Kent P Friedman; Heiko Schöder; Neeta Pandit-Taskar
Journal:  Transl Oncol       Date:  2022-05-03       Impact factor: 4.803

6.  Depiction of ventriculoperitoneal shunt obstruction with single-photon emission computed tomography/computed tomography.

Authors:  Sabire Yılmaz Aksoy; Betül Vatankulu; Lebriz Uslu; Metin Halac
Journal:  Indian J Nucl Med       Date:  2016 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.